» Articles » PMID: 6170296

Pharmacological and Toxicological Properties of Azelastine, a Novel Antiallergic Agent

Overview
Specialty Pharmacology
Date 1981 Jan 1
PMID 6170296
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

Effect of nasal antihistamine on secretory IgA in nasal lavage of rats.

Dogan R, Aksoy F, Sezen Goktas S, Kocak I, Yildirim Y, Incir S Eur Arch Otorhinolaryngol. 2017; 275(1):111-115.

PMID: 29052012 DOI: 10.1007/s00405-017-4750-1.


Effectiveness of azelastine nasal spray in the treatment of adenoidal hyper-trophy in children.

Berkiten G, Kumral T, Cakir O, Yildirim G, Salturk Z, Uyar Y Hippokratia. 2015; 18(4):340-5.

PMID: 26052201 PMC: 4453808.


A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.

Du D, Targett D, Stolberg E, Canali A Eur J Drug Metab Pharmacokinet. 2013; 39(1):69-75.

PMID: 23681835 DOI: 10.1007/s13318-013-0134-0.


Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis.

Williams P, Crandall E, Sheppard J Clin Ophthalmol. 2010; 4:993-1001.

PMID: 20856595 PMC: 2938280. DOI: 10.2147/opth.s13479.


Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

Horak F Ther Clin Risk Manag. 2009; 4(5):1009-22.

PMID: 19209282 PMC: 2621402. DOI: 10.2147/tcrm.s3229.